Infection prevention and control guidelines for patients with Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection.
نویسندگان
چکیده
منابع مشابه
Update: Recommendations for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
On June 11, 2013, CDC issued interim infection prevention and control recommendations for hospitalized patients with known or suspected Middle East respiratory syndrome coronavirus (MERS-CoV) infection in U.S. hospitals. To date, no MERS-CoV cases have been reported in the United States; however, cases have been reported in eight other countries. Recent published reports have described limited ...
متن کاملGenetics and epidemiology of Middle East Respiratory Syndrome-Coronavirus (MERS-CoV)
Background and aims: Middle East respiratory syndrome (MERS) is a viral respiratory illness caused by a coronavirus. After the primary onset of MERS in Saudi Arabia, in September 2015 cases began to increase. The number of laboratory-affirmed cases by MERS-CoV in the Middle East has been being increased recently. Methods: In this current review article, by using the terms “MERS” and “coronavir...
متن کاملHospital-associated Middle East respiratory syndrome coronavirus infections.
To the Editor: Assiri et al. (Aug. 1 issue)1 provide valuable information about a hospital outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. However, the authors do not describe the infection-control measures used in the hospital, and they do not discuss the possibility of aerosol transmission of MERS-CoV, a coronavirus similar to the severe acute respiratory syndro...
متن کاملMiddle East Respiratory Syndrome Coronavirus (mers-cov): Threat to Global Public Health & Challenges
Middle East respiratory syndrome coronavirus (MERS-CoV), a novel human coronavirus that caused outbreaks of a SARS-like illness in theMiddle East, is now considered a threat to global public health. As of 11 June 2014, 699 laboratory-confirmed cases of human infection with Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported to WHO including at least 209 deaths.This review...
متن کاملSingle-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection
Middle East respiratory syndrome coronavirus (MERS-CoV) is continuously spreading and causing severe and fatal acute respiratory disease in humans. Prophylactic and therapeutic strategies are therefore urgently needed to control MERS-CoV infection. Here, we generated a humanized monoclonal antibody (mAb), designated hMS-1, which targeted the MERS-CoV receptor-binding domain (RBD) with high affi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Saudi medical journal
دوره 35 8 شماره
صفحات -
تاریخ انتشار 2014